Product Information
Fluoroquinolone-based peptides, or FPTQs, are synthetic molecules that can bind to glutamate receptors and modify their function. They are being developed as a potential drug treatment for acute ischemic stroke. FPTQs were designed with two goals in mind: to target only neurons and not glial cells, and to prevent glutamate from activating the receptor. FPTQs have been shown to be effective at reducing neuronal death in animal models of stroke, but more research is needed before human clinical trials can be conducted.
Chemical properties
Technical inquiry about: 3D-PJB86372 FPTQ
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
